John Jiang
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Advanced Breast Cancer Therapies 4
- Renal cell carcinoma treatment 3
- Lung Cancer Treatments and Mutations 2
- Oncology 9
- Cancer Cells and Metastasis 3
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Yixin Wang (5 shared papers)Howard L. McLeod (1 shared paper)Yi Zhang (1 shared paper)Dmitri Talantov (1 shared paper)David Atkins (1 shared paper)Tim Jatkoe (1 shared paper)Matthew G. Mutch (1 shared paper)Sarah Hrebien (2 shared papers)
- Journals
- Cancer Research (4 papers)Cancer (2 papers)Journal of Clinical Oncology (2 papers)Journal of Molecular Diagnostics (2 papers)Clinical Chemistry (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
John Jiang
17 papers receiving 1.2k citations
John Jiang's Hit Papers
Peers
Comparison fields: 5 of 65
- Cancer Research 614
- Oncology 725
- Pulmonary and Respiratory Medicine 505
- Pathology and Forensic Medicine 262
- Molecular Biology 458
Countries citing papers authored by John Jiang
This map shows the geographic impact of John Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Jiang more than expected).
Fields of papers citing papers by John Jiang
This network shows the impact of papers produced by John Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Jiang. The network helps show where John Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside John Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2016 | 507 |
| 2 | 2004 | 356 | |
| 3 | 2019 | 71 | |
| 4 | 2009 | 70 | |
| 5 | 2001 | 44 | |
| 6 | 2011 | 41 | |
| 7 | 2019 | 36 | |
| 8 | 2012 | 31 | |
| 9 | 2012 | 28 | |
| 10 | 2011 | 19 | |
| 11 | 2013 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 11 | |
| 14 | 2007 | 6 | |
| 15 | 2016 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2012 | 1 |
About John Jiang
John Jiang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Cells and Metastasis (3 papers), Renal cell carcinoma treatment (3 papers), Genetic factors in colorectal cancer (2 papers), CRISPR and Genetic Engineering (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cancer Research (614 citations), Oncology (725 citations), Pulmonary and Respiratory Medicine (505 citations), Pathology and Forensic Medicine (262 citations) and Molecular Biology (458 citations). John Jiang has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Yixin Wang, Howard L. McLeod, Yi Zhang, Dmitri Talantov, David Atkins, Tim Jatkoe, Matthew G. Mutch, Sarah Hrebien, Nicholas C. Turner and Massimo Cristofanilli. Their work appears in journals such as Cancer Research, Cancer, Journal of Clinical Oncology, Journal of Molecular Diagnostics and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.